Indian Carfilzomib Exporters: Complete Supplier Ranking with Market Share — 65 Manufacturers (2026) — TransData Nexus

Q: Who is the largest carfilzomib supplier from India?

MSN LABORATORIES PRIVATE LIMITED is the largest carfilzomib exporter from India with a 7.5% market share and export value of $90.9K.

Q: How many carfilzomib suppliers are there in India?

There are 65 active carfilzomib exporters in India, collectively shipping $1.2M worth of carfilzomib across 203 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top carfilzomib suppliers from India?

The top 5 carfilzomib suppliers from India — MSN LABORATORIES PRIVATE LIMITED, SARTAJ PHARMA PRIVATE LIMITED, NATCO PHARMA LIMITED, 3S CORPORATION, RGSK CANADA HEALTHCARE INC. — together control 17.1% of total carfilzomib export value from India.

Suresh Sormare

Carfilzomib

India Pharmaceutical Trade Intelligence

$1.2M65 Suppliers47 CountriesHS 30049049

ExportsIndia → RUSSIA60.7%India → CHILE7.4%

ImportsIRELAND → India$9.4M CANADA → India$518.8K

#1 Supplier: MSN LABORATORIES

Carfilzomib Suppliers from India (2026) — 65 Exporters, $1.2M Market | TransData Nexus | TransData Nexus

Who Exports Carfilzomib from India — 65 Suppliers Behind a $1.2M Market

India's carfilzomib export market is supplied by 65 active exporters who collectively shipped $1.2M across 203 shipments. MSN LABORATORIES PRIVATE LIMITED leads with a 7.5% market share, followed by SARTAJ PHARMA PRIVATE LIMITED and NATCO PHARMA LIMITED. The top 5 suppliers together control 17.1% of total export value, reflecting a moderately competitive market structure.

Source: Indian Customs (DGFT)·Published April 2026

India's Top Carfilzomib Suppliers & Exporters — 65 manufacturers, $1.2M export market, top destinations and formulations — Carfilzomib supplier data — 65 exporters · $1.2M market · 203 shipmentsTransData Nexus · Indian Customs Data

Top Carfilzomib Exporters from India — Ranked by Export Value

MSN LABORATORIES PRIVATE LIMITED is the leading carfilzomib exporter from India, holding a 7.5% share of the $1.2M market across 203 shipments from 65 exporters. The top 5 suppliers — MSN LABORATORIES PRIVATE LIMITED, SARTAJ PHARMA PRIVATE LIMITED, NATCO PHARMA LIMITED, 3S CORPORATION, RGSK CANADA HEALTHCARE INC. — collectively control 17.1% of total export value, indicating a competitive market. Individual shares are: MSN LABORATORIES PRIVATE LIMITED (7.5%), SARTAJ PHARMA PRIVATE LIMITED (2.7%), NATCO PHARMA LIMITED (2.6%), 3S CORPORATION (2.2%), RGSK CANADA HEALTHCARE INC. (2.1%).

Top Carfilzomib Exporters from India

Ranked by export value · 65 active suppliers · Indian Customs (DGFT) data

Apr 2026

Top Carfilzomib Exporters from India — Ranked by Export Value. 65 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Carfilzomib exporters

Certification and compliance status for top Carfilzomib suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
MSN LABORATORIES PRIVATE LIMITED	Not Listed	Yes, as of January 2	No	Not verified	WHO-GMP certification confirmed by CDSCO as of January 2026.
NATCO PHARMA LIMITED	Warning Letter, April 202	Yes, as of January 2	No	Not verified	Received FDA warning letter in April 2024; WHO-GMP certification confirmed by CD

TransData Nexus reviewed the regulatory standing of 2 leading Carfilzomib exporters from India. 0 hold US FDA facility approvals, 2 maintain WHO-GMP certification, and 0 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Carfilzomib sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for Active Pharmaceutical Ingredients (APIs) and bulk drug manufacturing. The city hosts over 800 pharmaceutical companies, including industry leaders such as Dr. Reddy's Laboratories, Aurobindo Pharma, and Divi's Laboratories. This concentration of expertise and infrastructure makes Hyderabad a significant player in the production of complex APIs like Carfilzomib. Notably, Dr. Reddy's Laboratories, headquartered in Hyderabad, is recognized as a leading manufacturer and supplier of Carfilzomib API, leveraging over 30 years of experience in developing complex molecules.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations and finished dosage forms. This region contributes nearly 28% of India's pharmaceutical production and is home to major companies such as Zydus Lifesciences (formerly Cadila Healthcare), Intas Pharmaceuticals, and Torrent Pharmaceuticals. These companies are instrumental in the formulation and export of Carfilzomib-based products. For instance, Intas Pharmaceuticals manufactures Carfizome, a Carfilzomib injection, while Zydus Lifesciences has a significant presence in the oncology segment.

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Carfilzomib exporters from India

November 12, 2025

M&A

NATCO Pharma Limited — NATCO Pharma acquires 35.75% stake in Adcock Ingram

NATCO Pharma completed the acquisition of a 35.75% stake in Adcock Ingram, a South African pharmaceutical company, for approximately US$226 million. This acquisition led to the delisting of Adcock Ingram from the Johannesburg Stock Exchange. - IMPACT: This strategic move is expected to enhance NATCO's global distribution network, potentially increasing Carfilzomib exports to South Africa and neighboring regions.

Impact: This strategic move is expected to enhance NATCO's global distribution network, potentially increasing Carfilzomib exports to South Africa and neighboring regions.

January 1, 2022

M&A

NATCO Pharma Limited — NATCO Pharma completes acquisition of Dash Pharmaceuticals LLC

NATCO Pharma Inc., a wholly owned subsidiary of NATCO Pharma Limited, completed the acquisition of Dash Pharmaceuticals LLC, a New Jersey-based entity. The acquisition amount was US$18 million. Dash is a front-end pharmaceutical sales, marketing, and distribution entity in the USA, expected to have net sales of approximately USD 15 million for the financial year ending December 2021. - IMPACT: This acquisition provides NATCO with a direct platform to engage with customers in the USA, potentially boosting Carfilzomib exports to the American market.

Common Questions — Carfilzomib Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which carfilzomib supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, MSN LABORATORIES PRIVATE LIMITED leads with 19 recorded shipments worth $90.9K. SARTAJ PHARMA PRIVATE LIMITED (7 shipments) and NATCO PHARMA LIMITED (7 shipments) are also established high-volume exporters.

Q How many carfilzomib manufacturers are there in India?

India has 65 active carfilzomib exporters with a combined export market of $1.2M across 203 shipments to 47 countries. The top 5 suppliers hold 17.1% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Carfilzomib

Carfilzomib

Who Exports Carfilzomib from India — 65 Suppliers Behind a $1.2M Market

Top Carfilzomib Exporters from India — Ranked by Export Value

Top Carfilzomib Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

NATCO Pharma Limited — NATCO Pharma acquires 35.75% stake in Adcock Ingram

NATCO Pharma Limited — NATCO Pharma completes acquisition of Dash Pharmaceuticals LLC

Common Questions — Carfilzomib Suppliers from India

Q Which carfilzomib supplier from India is the most reliable for bulk orders?

Q How many carfilzomib manufacturers are there in India?

Q What certifications should I verify?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Sun Pharmaceutical Industries Ltd. — Sun Pharma enters licensing agreement with Pharmazz Inc.

Q What is the typical price range for carfilzomib from India?

Analysis Methodology